ARCHIVES

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

Report Redefines Cancer Control Research, Sets the Agenda For Newest NCI Division

October 17, 1997

Amgen’s Aranesp Sales Dropped By Half, Continue To Fall.

November 14, 2008

Clinical Trials Approved By NCI

September 26, 2003

In Brief: UC Irvine Wins Grant For Trial Of One-Visit Cervical Cancer Screening, Treatment

November 6, 1998

Guidelines Adopted For Pathology Review

February 22, 1980

NCI Alternative to Fixed Number Of Grants Not Popular At NIH; AACR Considers New Issues Groups

July 15, 1983